Algorithm for Bone Marrow Examination

 

·       Clinical History

·       Indication

·       Meds / Chemo / Growth Factors

·       Peripheral Blood:

·       Automated differential

·       Algorithm for peripheral blood examination

·       Aspirate:

·       Adequacy (10x objective)

·       Number and cellularity of particles (squash is best for cellularity)

·       Number of megakaryocytes (squash is best)

·       Dilute: absence of particles but presence of megakaryocytes or other precursor cells

·       (Hypocellular, Inadequate for interpretation precluding a differential)

·       Number of smears, number of touch preps

·       Scan for clumps of abnormal cells or scattered abnormal cells (10x) (squash is best for focal lesions including lymphoma, plasma cell myeloma, mast cells, metastatic carcinoma, storage histiocytes, granulomas)

·       Parasites

·       Cell inclusions

·       Differential (smears are best) (at least 500 cells in at least 2 smears if a precise percentage of abnormal cell type is required; otherwise at least 300 cells)

·       # of cells counted

·       Blasts

·       Promyelocytes

·       Myelocytes

·       Metamyelocytes

·       Bands

·       PMNs

·       Eos Myelo/Meta

·       Eos Band

·       Eos Seg

·       Basophils

·       Mast cells

·       Promonocytes

·       Monocytes

·       Pronormoblasts

·       Normoblasts

·       Lymphocytes

·       Plasma cells

·       Other

·       Don’t include:

·                   Megakaryocytes

·       Macrophages

·       Osteoblasts

·       Osteoclasts

·       Stromal cells

·       Smudged cells

·       Non-haemopoietic cells

·       Lymphoid aggregates

·       Myeloid:Erythroid (normal 1.5 – 3.3)

·       Myeloid includes all granulocytes and monocytes and their precursors

·       Erythroid includes all stages of differentiation

·       Cellularity (squash prep is best)

·       (mildly, moderately, markedly)

·       (increased, decreased, unremarkable, not evaluable)

·       Erythroid maturation

·       (complete, slight, moderate, marked, megaloblastoid, megaloblastic, asynchronous)

·       dyserythropoietic forms

·       Myeloid maturation

·       (complete, slight, moderate, marked)

·       megaloblastoid, megaloblastic

·       with a left shift

·       with dysplastic forms

·       with pseudo-Pelger-Huet forms

·       Megakaryocytes:

·       (present in, absent)

·       (mildly, moderately, markedly)

·       (increased, decreased, normal) numbers

·       with clusters, aggregates, very large aggregates present

·       monolobate

·       hypersegmented

·       small

·       non-budding

·       dysplastic forms

·       Biopsy:

·       Adequacy

·       Fragmented

·       Crushed

·       Inadequate for interpretation

·       Hemorrhagic

·       Contains a large amount of cartilage, cortical bone, periosteum

·       Clot section / particle preparation:

·       Adequacy

·       Fragmented

·       Crushed

·       Inadequate for interpretation

·       Stainable iron (smear is best; less reliable on decalcified specimen):

·       (absent, decreased, normal, increased, markedly increased)

·       ringed sideroblasts

·       (no, rare, moderate numbers of, numerous) (at least 100 erythroblasts should be evaluated for the percentage of ring sideroblasts, if present)

·       definition: 5 or more siderotic granules encircling one third or more of the nucleus

·       location (cytoplasmic or perinuclear) of siderotic granules

·       Focal lesions

·       Bony trabeculae

·       (unremarkable, thinned, show osteoclastic resorption, osteoblastic rimming, show new bone formation)

·       Cytochemical stains

·       Immunohistochemical stains

·       in situ hybridization

·       Comparison to previous BM sample

 

References:

·       Steven H. Swerdlow.  University of Pittsburgh School of Medicine Department of Pathology.  Hematopathology handbook for residents and fellows.

·       Lee S-H, Erber WN, Porwit A, Tomonaga M, Peterson LC for the International Council for Standardization in Hematology.  ICSH guidelines for the standardization of bone marrow specimens and reports.  Int J Lab Hem 2008;30:349-364.